slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 94,501-94,530
Pages 3,950
Rows per page 30
Component
94,501-94,530 of 118,471
03
Hepion Pharmaceuticals | Results Presentation Deck | 34 slidesHepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
12
Hepion Pharmaceuticals | Results Presentation Deck | 34 slidesHepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
16
The slide outlines a 42-day study timeline with a 28-day treatment period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
19
The diagram uses a brain visualization to represent the integration of AI technologies into the central AI-POWR platform.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
20
Uses a funnel diagram to represent the filtering of patient data into responders and non-responders.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The slide uses a network graph to visualize gene interactions, categorized by color-coded functional groups.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
The slide outlines a randomized clinical trial structure with a 1:1:1:1 ratio, a 12-month treatment period, and a 1-month follow-up.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
The slide outlines a randomized clinical trial structure with three dosing arms and a follow-up period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
27
Hepion Pharmaceuticals | Results Presentation Deck | 34 slidesHepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
29
Includes specific stopping rules for futility based on Disease Control Rate (DCR).Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
33
Hepion Pharmaceuticals | Results Presentation Deck | 34 slidesHepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
34
Hepion Pharmaceuticals | Results Presentation Deck | 34 slidesHepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
01
Hilltop Holdings | Results Presentation Deck | 19 slidesHilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations 1 hit
01
IBM | Results Presentation Deck | 29 slidesIBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · AttentionLoop · Cost Of Inaction1 hit
04
IBM | Results Presentation Deck | 29 slidesIBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · AttentionLoop · Cost Of Inaction1 hit
06
Includes a quote from James Kavanaugh, IBM SVP & CFO.IBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Need1 hit
11
IBM | Results Presentation Deck | 29 slidesIBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Action1 hit
19
Values are in billions of dollars.IBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Action1 hit
20
The table breaks down net cash from operations, free cash flow, and changes in cash and marketable securities.IBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Action1 hit
22
The donut chart visualizes the sub-segments of the 'Hybrid Platform & Solutions' category, not the total revenue split between the two main categories.IBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Action1 hit
29
IBM | Results Presentation Deck | 29 slidesIBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Action1 hit
06
The slide uses a simple three-pillar process diagram to summarize the company's core business model.IGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank 1 hit
10
The slide uses a visual trend line connecting two data points to illustrate market growth.IGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
13
IGI | IPO Presentation Deck | 23 slidesIGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank Beat · Product1 hit
22
IGI | IPO Presentation Deck | 23 slidesIGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank Beat · The Ask1 hit
04
The slide uses a process flow diagram to show the progression of clinical trial cohorts.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
06
The slide uses a before-after framework to contrast the focus areas of two clinical trial phases, followed by a numbered list of specific improvements.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
11
The slide uses waterfall charts to visualize clinical trial efficacy across various solid tumor types.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
20
Immatics | Results Presentation Deck | 25 slidesImmatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations 1 hit
08
Includes adjustments for PPP, acquisition fair value marks, nonaccrual interest, and other noncore items.Independent Bank Corp | Results Presentation Deck | 14 slides · Independent Bank Corp
Regulatory filing Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit